White cell deficiency and TET2 and SRSF2 gene mutations
DOI:
https://doi.org/10.5564/pib.v38i1.2547Keywords:
SRSF2 gene mutationsAbstract
No abstract in English
Цагаан эсийн дутагдал ба TET2, SRSF2 генийн мутаци
89
References
V. Visconte, R. V. Tiu, and H. J. Rogers, “Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease,” Blood Res., vol. 49, no. 4, pp. 216–227, Dec. 2014, https://doi.org/10.5045/br.2014.49.4.216.
E. Papaemmanuil et al., “Clinical and biological implications of driver mutations in myelodysplastic syndromes,” Blood, vol. 122, no. 22, pp. 3616–3627, Nov. 2013, https://doi.org/10.1182/blood-2013-08-518886.
S. Jaiswal et al., “Age-related clonal hematopoiesis associated with adverse outcomes,” N. Engl. J. Med., vol. 371, no. 26, pp. 2488–2498, Dec. 2014, https://doi.org/10.1056/NEJMoa1408617.
Downloads
Published
How to Cite
License
Copyright (c) 2022 Bumbein Dashnyam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright on any research article in the Proceedings of the Institute of Biology is retained by the author(s).
The authors grant the Proceedings of the Institute of Biology license to publish the article and identify itself as the original publisher.
Articles in the Proceedings of the Institute of Biology are Open Access articles published under a Creative Commons Attribution-NonCommercial 4.0 International License - CC BY NC.
This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
